Astaxanthin
(as' × tä × zan'× thin)

Medical researchers have shown that ASTAXANTHIN may have significant pharmaceutical applications. In-vitro experiments, in-vivo pre-clinical studies and early-stage clinical trials have clearly indicated the possibility that ASTAXANTHIN itself, or in conjunction with other components, behaves like a prophylactic and curing agent against various diseases and health conditions.

What is Astaxanthin?

Astaxanthin is the main carotenoid pigment found in aquatic animals. This red-orange pigment is closely related to other well-known carotenoids such as beta-carotene or lutein, but has a stronger antioxidant activity (10 times higher than beta-carotene). Studies suggest that Astaxanthin can be 1000 times more effective as an antioxidant than vitamin E.

In many of the aquatic animals where it can be found, Astaxanthin has a number of essential biological functions, ranging from protection against oxidation of essential polyunsaturated fatty acids, protection against UV-light effects, pro-vitamin A activity and vision, immune response, pigmentation, and communication, to reproductive behavior and improved reproduction.

In species such as salmon or shrimp, Astaxanthin is even considered as essential to normal growth and survival, and has been attributed vitamin-like properties. Some of these unique properties have also been found to be effective in mammals and open very promising possibilities for nutraceutical and pharmaceutical applications of Astaxanthin in humans.

Where Is Astaxanthin Found in Nature?

It can be found in many of our favorite seafood such as salmon, trout, red seabream, shrimp, lobster and fish eggs. It is also found in a number of bird species. Astaxanthin cannot be synthesized by animals and must be provided in the diet, as is the case with other carotenoids. While fish such as salmon are unable to convert other dietary carotenoids into Astaxanthin, some species such as shrimp have a limited capacity to convert closely related dietary carotenoids into Astaxanthin, although they will benefit strongly from being fed Astaxanthin directly.

Mammals are also unable to synthesize Astaxanthin. Some microorganisms can be quite rich in Astaxanthin. Ubiquitous micro-algae, Haematococcus pluvialis is believed to be the organism, which can accumulate the highest levels of Astaxanthin in nature.

The function of Astaxanthin

The function of Astaxanthin appears to be to protect the algae from adverse environment changes, such as increased UV-light photoxidation and evaporation of the water pools in which it lives.

Haematococcus algae can accumulate as high as 10 to 30 g of Astaxanthin per kg of dry biomass. This level is 1,000 to 3,000 fold higher than in salmon fillets! Some strains have even been observed to accumulate as much as 70 to 80 g of Astaxanthin per kg of dry biomass.

More on Astaxanthin?

Astaxanthin is a red pigment occurring naturally in a variety of living organisms. Although the word Astaxanthin may not be commonly encountered in everyday speech, the pigment itself is found in many human foods, and you are quite likely to be consuming it in your diet already. Most crustaceans, including shrimp, crawfish, crabs and lobster, are tinted red by accumulated Astaxanthin. The coloration of fish is often due to Astaxanthin; the pink flesh of a healthy wild salmon is a conspicuous example. In commercial fish and crustacean farms, Astaxanthin is commonly added to feeds in order to make up for the lack of a natural dietary source of the pigment (Torrissen et al. 1989).

Not only does Astaxanthin provide for pigmentation in these farmed animals, it also has been found to be essential for their proper growth and survival (Torrissen and Christiansen 1995).

Astaxanthin is one of a group of natural pigments known as carotenoids. In nature, carotenoids are produced principally by plants and their microscopic relatives, the microalgae. Animals cannot synthesize carotenoids de novo, thus ultimately they must obtain these pigments from the plants and algae that support their food chains (Britton et al. 1995).

Commercial production of Astaxanthin from the microalga Haematococcus pluvialis is a growing business worldwide, primarily due to the rapid growth of this microorganism and its high Astaxanthin content. Other commercial ventures for natural Astaxanthin production utilize fermentation of the pink yeast Xanthophyllomyces dendrorhous or extraction of the pigment from by-products of crustacea such as the Antarctic krill (Euphausia superba). In addition to production from natural sources, Astaxanthin may be chemically synthesized, and synthetic Astaxanthin is the major form currently being used in fish feeds (McCoy 1999).

The Astaxanthin molecule is similar to that of the familiar carotenoid beta-carotene, but the small differences in structure confer large differences in the chemical and biological properties of the two molecules. In particular, Astaxanthin exhibits superior antioxidant properties to beta-carotene in a number of in vitro studies (Terao 1989; Miki 1991; Palozza and Krinsky 1992; Lawlor and O'Brien 1995).

While the positive effects of Astaxanthin on farmed fish and crustaceans have been recognized for years, the potential benefits of this powerful antioxidant to human health are only now being revealed.

More on Astaxanthin: In the Pink

We accept the vibrancy of life around us as normal daily occurrences. We walk through a bird aviary and ooh and ahh at feathers of flamingos. We enjoy the delectable pink taste of shrimp or salmon without understanding that within that pink nestles an antioxidant ready to combat the free radicals that assault our bodies daily. Astaxanthin is that same red-orange carotenoid pigment found in aquatic animals or in the feathers of the more exotic bird variety. Not only does it add a splash of color to life, it also ranks as one of the strongest antioxidants known to man.

It actually beats, ten times, beta-carotene's strength and research has shown it to be more effective than both vitamin C and E. (Jyonouchi, H., L. Zhang, M. Gross, and Y. Tomita. 1994 Immunomodulating actions of carotenoids: Enhancement of in vivo and in vitro antibody production to T-dependent antigens. Nutr. Cancer 21:47-58)

Antioxidants are absolutely necessary in maintaining a healthy body. Within our bodies are little rascals known as free radicals. Free radicals are highly unstable molecules due to their lack of one unpaired electron, making them "jealous" of and dangerous to other molecules. This "envy" motivates them to rip an electron from a stable molecule, causing a once healthy molecule to become unsteady. Once a free radical damages a molecule, that molecule follows suit and damages other molecules starting a vicious chain of events. Some doctors and scientists theorize that free radicals promote aging and all its effects. Unfortunately, we can't stop free radicals since they're oxygen based.

Every time we breathe, oxygen molecules pass into our lungs, travel through our blood stream, and are delivered to cells that consume oxygen for energy and for building proteins. But what's good for the goose, is not always good for the gander and the highly reactive oxygen can throw some molecules off, leaving them with an extra or stripped of one electron. If this only happened once in a while, free radicals would not be so worrisome but, unluckily for us and our cells and DNA, each cell can receive 1,000 hits by free radical activity in a 24-hour period!

Since we need to breathe and oxygen is essential, doctors and scientists have discovered that nature has developed a free radical clean-up crew referred to as antioxidants. Astaxanthin is an antioxidant that goes the extra mile. Since it has a low molecular weight, it can pass the blood-brain barrier where it works it's antioxidant magic on the eye, brain, and central nervous system. It also has a longer life span and is resistant to damage, allowing it a longer amount of time to escort free radicals from cells to other antioxidants like vitamin C.

Looking at past studies, it is clear that cartenoids can influence different aspects of the immune system. They can stimulate the T-helper cells, improve rejection of foreign tissue, and increase the action of natural killer cells that destroy tumor cells and fungi. Our immune systems are constantly bombarded with foreign and harmful substances, and any assistance it can receive from an antioxidant is always welcome. When all of these factors add up, Astaxanthin proves itself to be a powerful ally to the body.

So do yourself a favor, add a splash of color to your life by supplementing your diet with food containing Astaxanthin from the antioxidant's natural occurring and strongest source, the algae Haematococcus, a fresh water microalgae. It's a natural source to saving your life and keeping you healthy.

Frequently Asked Questions

1. What is Astaxanthin?

Astaxanthin is a member of the carotenoid family. These molecules are associated with many of the colors that you see in leaves, flowers and fruit. They are one of the most abundant molecules in the world and give nature its wide variety of colors. Carotenoids have a long structure called the polyene system and may also have ring groups at one or either end.

The differences in the polyene and ring structures are what varies the carotenoids and their corresponding colors due to different light absorbencies. Astaxanthin is a red pigment and the predominant carotenoid of most crustacean species. Interestingly, when Astaxanthin binds to different protein, it can appear green, yellow, blue or brown. When these "carotenoproteins" are denatured by cooking, Astaxanthin is released and the red color becomes apparent again.

2. What types of Astaxanthin are currently available?

At this time, the primary source of Astaxanthin and carotenoids are mostly synthetic forms produced by chemical means. There are also natural sources available from processed krill, crawfish and yeast and from Haematococcus algae, the most concentrated source of natural Astaxanthin that is available.

3. What are the benefits of using an algae source for Astaxanthin compared to the other natural forms?

The krill, crawfish and Phaffia sources contain low concentrations of Astaxanthin. Feeds may require so much addition of these products for effective pigmentation that it adds unwanted bulk and ash, decreases palatability, and alters the nutrient balance of the diet. The Astaxanthin derived from Haematococcus algae is the most concentrated source of natural Astaxanthin that is available.

Research

There is a large body of research available on Astaxanthin. Several scientific papers have been written on medical and neutraceutical applications of Astaxanthin. Medical researchers have shown that ASTAXANTHIN may have significant pharmaceutical applications. In-vitro experiments, in-vivo pre-clinical studies and early-stage clinical trials have clearly indicated the possibility that ASTAXANTHIN itself, or in conjunction with other components, behaves like a prophylactic and curing agent against various diseases and health conditions (See Tables 1 and 2).


TABLE 1. SELECTED PATENTS ON ASTAXANTHIN APPLICATIONS IN HEALTH AND NUTRITION

PATENT NUMBER - COMPANY - PATENT TITLE

EP0786990 - US NUTRACEUTICALS USE OF ASTAXANTHIN FOR RETARDING AND AMELIORATING CENTRALNERVOUS SYSTEM AND EYE DAMAGE

EP1217996 - ASTACAROTENE USE OF ASTAXANTHIN FOR TREATMENT OF AUTOIMMUNE DISEASES,CHRONIC VIRAL AND INTRACELLULAR BACTERIAL INFECTIONS

US6475547 - ASTACAROTENE Immunoglobulin-rich milk, production and use thereof

WO0023064 - ASTACAROTENE TREATMENT OF DYSPEPSIA

US6410602 - ASTACAROTENE Method of increasing the production and improving the quality of semen

US6335015 - ASTACAROTENE Method of the prophylactic treatment of mastitis

US6262316 - ASTACAROTENE Oral preparation for the prophylactic and therapeutic treatment ofHELICOBACTER SP. infection

US6245818 - ASTACAROTENE Medicament for improvement of duration of muscle function or treatmentof muscle disorders or diseases

US6054491 - ASTACAROTENE Agent for increasing the production of/in breeding and production mammals

US5744502 - ASTACAROTENE Method for increasing the production of/in breeding and productionA NIMALS IN the poultry industry

US6433025 - CYANOTECH Method for retarding and preventing sunburn by UV light

US6344214 - CYANOTECH Method for retarding and ameliorating fever blisters and canker sores

US6258855 - CYANOTECH Method of retarding and ameliorating carpal tunnel syndrome

EP1283038 - SUNTORY LTD COMPOSITIONS NORMALIZING CIRCADIAN RHYTHM

WO03013556 - ITAKURA HIROSHIGE MEDICINAL COMPOSITIONS HAVING EFFECTS OF AMELIORATINGEYE DISEASES AND HOLDING EYE FUNCTIONS

WO03003848 - AANESEN BERIT ANNIE THE USE OF DI-ESTERS OF ASTAXANTHIN FOR ENHANCING THE GROWTH OFFARMED FISH

WO02094253 - FUJI CHEM IND CO AGENTS FOR RELIEVING EYE CONTROLLING FUNCTION ERROR

KR2000045197 - PACIFIC CO LTD HEALTHY NUTRITION COMPOSITION CONTAINING CHITOSAN OLIGOSACCHARIDEAND ASTAXANTHIN

WO02058683 - LYCORED CAROTENOIDS AS ANTI-HYPERTENSION AGENTS

NZ299641 - SUNTORY AND ITANO Use of astaxanthin in pharmaceuticals for treating stress

US6277417 - TRIARCO Method OF INHIBITING 5alpha-reductase with astaxanthin

US2003/778304 - anderson AND PETTERSON METHOD OF INHIBITING THE EXPRESSION OF INFLAMMATORY CYTOKINES AND CHEMOKINES

JP10276721 - SUNTORY AND ITANO ASTAXANTHIN-CONTAINING FOOD OR DRINK

TABLE 2. - ELECTED ARTICLES ON ASTAXANTHIN APPLICATIONS FOR HUMAN AND MAMMALIAN HEALTH

Conditions and reference numbers found next in References

Central nervous system and neurodegradative diseases - 6
Eye health - 6, 23 - 26
Joint health, muscle endurance - 27, 28
Inflammation and immune system - 5, 29 - 46
Cardiovascular, heart, Lipid peroxidation and blood - 47 - 53
Cancer - 49, 54 - 65
Fertlity - 66, 67
Sunburn and skin health, anti-aging and anti-wrinkling - 26, 68 - 72
Benign prostatic hyperplasia (BPH) - 73

REFERENCES

1-Boussiba S.; Vonshak A.; Cohen Z.; Richmond A. (1997)
A procedure for large scale production of Astaxanthin from Haematococcus. WO 97/28274.

2- Papas, A.M. (1999)
Antioxidant Status, Diet, Nutrition, and Health. CRC Press.

3- Palozza, P. and Krinsky, N.I. (1992)
Astaxanthin and canthaxanthin are potent antioxidants in a membrane model. Arch. Biochem. Biophys. 297: 291–295.

4- Naguib, Y.M.A. (2000)
Antioxidant activities of astaxanthin and related carotenoids. J. Agric. Food Chem. 48: 1150–1154.

5- Chew B.P. and Park J.S., (October 2003)
Dissertation in Supply Side West. Las Vegas.

6- Tso, M.O.M. and Lam, T-T. (1996)
Method of Retarding and Ameliorating Central Nervous System and Eye Damage. Assigned to U. S. Nutraceuticals. U.S. Patent #5527533.

7- Facchinetti F.; Dawson VL.; Dawson TM. (1998)
Free radicals as mediators of neuronal injury. Cell Mol Neurobiol.18(6):667-82.

8- Lorenz, R.T. and Cysewski, G.R. (2000)
Commercial potential for Haematococcus microalgae as a natural source of astaxanthin. Trends in Biotechnol. 18: 160–167.

9 - Guerin, M.; Huntley M. E.; and Olaizola M. (2003)
Haematococcus astaxanthin: applications for human health and nutrition. Trends in Biotechnol. 21: 210-216.

10- Shibata A.; Kiba Y.; Akati N.; Fukuzawa K.; Terada H. (2001)
Molecular characteristics of astaxanthin and beta-carotene in the phospholipid monolayer and their distributions in the phospholipid bilayer. Chem Phys Lipids113(1-2): 11-22.

11- Goto S.; Kogure K.; Abe K.; Kimata Y.; Kitahama K.; Yamashita E.; Terada H. (2001)
Efficient radical trapping at the surface and inside the phospholipid membrane is responsible for highly potent antiperoxidative activity of the carotenoid astaxanthin. Biochim Biophys Acta1512(2): 251-8.

12- Oshima S.; Ojima F.; Sakamoto H.; Ishiguro Y.; Terao J. (1993)
Inhibitory effect of beta-carotene and astaxanthin on photosensitized oxidation of phospholipid bilayers. J Nutr Sci Vitaminol (Tokyo) 39(6): 607-15.

13- Kurashige M.; Okimasu E.; Inoue M.; Utsumi K. (1990)
Inhibition of oxidative injury of biological membranes by astaxanthin. Physiol Chem Phys Med NMR 22(1): 27-38.

14 - Nakagawa K.; Kang SD.; Park DK.; Handelman GJ.; Miyazawa T. (1997)
Inhibition of beta-carotene and astaxanthin of NADPH-dependent microsomal phospholipid peroxidation. J Nutr Sci Vitaminol (Tokyo) 43(3): 345-55.


15– Bahner, B. (1993)
Beta –carotene use grows; natural sector in flux. Chemical Market Reporter 244:26-27.
16- Cyanotech Corporation
Technical paper available at: http://www.cyanotech.com/pdfs/axbul60.pdf

17 - Mera Pharmaceuticals (1999)
Haematococcus pluvialis and astaxanthin safety for human consumption.
Technical Report TR.3005.001
available at
http://www.astafactor.com/techreports/tr3005-001.htm

18 – La Haye - US Nutraceuticals
technical paper available at: http://www.lahaye.com/safety.html

19- Spiller GA.; Dewell A. (2003)
Safety of an Astaxanthin-Rich Haematococcus pluvialis Algal Extract: A Randomized Clinical Trial. J Med Food 6(1): 51-6.

20- Turujman, S.A. et al. (1997)
Rapid liquid chromatographic method to distinguish wild salmon from aquacultured salmon fed synthetic astaxanthin. J. AOAC Int. 80: 622–632.

21- Mercke Odeberg J.; Lignell A.; Pettersson A.; Hoglund P. (2003)
Oral bioavailability of the antioxidant astaxanthin in humans is enhanced by incorporation of lipid based formulations. Eur J Pharm Sci 19(4): 299-304.

22- Clark RM.; Yao L.; She L.; Furr HC. (2000)
A comparison of lycopene and astaxanthin absorption from corn oil and olive oil emulsions. Lipids 35(7): 803-6.

23 - Snodderly D.M. (1995)
Evidence for protection against age related macular degeneration by caretonoids and antioxidant vitamins. Amer J. Clinical Nutrition. 63(s):1448S-1461S.

24- Ohgami K.; Shiratori K.; Kotake S.; Nishida T.; Mizuki N.; Yazawa K.; Ohno S. (2003)
Effects of astaxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo. Invest Ophthalmol Vis Sci . 44(6): 2694-701.

25 - Waagbo R.; Hamre K.; Bjerkas E.; Berge R.; Wathne E.; Lie O.; Torstensen B. (2003)

Cataract formation in Atlantic salmon, Salmo salar L., smolt relative to dietary pro- and antioxidants and lipid level . J Fish Dis. 26(4): 213-29.

26- O'Connor I.; O'Brien N. (1998)
Modulation of UVA light-induced oxidative stress by beta-carotene, lutein and astaxanthin in cultured fibroblasts. J Dermatol Sci . 16(3): 226-30.

27 - Malmsten C. (1998)
Dietary supplementation with astaxanthin rich algal meal improves muscle endurance – a double blind study on male students. Unpublished study from the Karolinska Institute. Gustavberg, Sweden.


28- Lignell A. (2001)
Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseased. US patent # 6,245,818 Astacarotene AB Sweden.

29- Bennedsen, M. et al. (1999)
Treatment of H. pylori infected mice with antioxidant astaxanthin reduces gastric inflammation, bacterial load and modulates cytokine release by splenocytes. Immunol. Lett. 70: 185–189.
30- Wang X.; Willen R.; Wadstrom T. (2000)
Astaxanthin-rich algal meal and vitamin C inhibit Helicobacter pylori infection in BALB/cA mice. Antimicrob Agents Chemother 44(9): 2452-7.

31-Lignell, A. (1998)
Treatment of Dyspepsia, Patent no. WO 00/23064

32- Anderson T.; Pettersson S. (2001)
Method of inhibiting the expression of inflammatory cytokines. Patent no. WO 0172296.

33- Lorenz T. et al. (2000)
Method of retarding Ameliorating Carpel tunnel syndrome, US Patent #. 6,258,855.

34- Hughes D.A. (1999)
Effects of dietary antioxidants on the immune function of the middle aged. Proc. Nutr. Soc 58(1): 79-84.

35- Lignell A. (2001)
Use of xanthophylls, Astaxanthin e.g. for the treatment of autoimmune diseases, chronic viral and intracellular bacterial infections. Patent # WO 01/24787.

36- Lignell A. et al. (1998)
Method for the prophylactic treatment of mastitis. WO99/30701.

37- Jyonouchi, H. et al. (1995)
Effect of carotenoids on in vitro immunoglobulin production by human peripheral blood mononuclear cells: astaxanthin, a carotenoid without vitamin A activity, enhances in vitro immunoglobulin production in response to a T-dependent stimulant and antigen. Nutr. Cancer 23: 171–183.

38- Lee SJ.; Bai SK.; Lee KS.; Namkoong S.; Na HJ.; Ha KS.; Han JA.; Yim SV.; Chang K.; Kwon YG.; Lee SK.; Kim YM. (2003)
Astaxanthin inhibits nitric oxide production and inflammatory gene expression by suppressing I(kappa)B kinase-dependent NF-kappaB activation. Mol Cells Korea 16(1): 97-105.

39- Chew BP.; Wong MW.; Park JS.; Wong TS. (1999)
Dietary beta-carotene and astaxanthin but not canthaxanthin stimulate splenocyte function in mice. Anticancer Res. 19(6B): 5223-7.

40- Jyonouchi H.; Zhang L.; Tomita Y. (1993)
Studies of immunomodulating actions of carotenoids. II. Astaxanthin enhances in vitro antibody production to T-dependent antigens without facilitating polyclonal B-cell activation. Nutr Cancer 19(3): 269-80.

41- Jyonouchi H.; Hill RJ.; Tomita Y.; Good RA. (1991)
Studies of immunomodulating actions of carotenoids. I. Effects of beta-carotene and astaxanthin on murine lymphocyte functions and cell surface marker expression in in vitro culture system. Nutr Cancer 16(2): 93-105.

42- Akyon Y. (2002 )
Effect of antioxidants on the immune response of Helicobacter pylori. Clin Microbiol Infect. 8(7): 438-41.

43- Okai Y.; Higashi-Okai K. (1996)
Possible immunomodulating activities of carotenoids in in vitro cell culture experiments. Int J Immunopharmacol 18(12): 753-8.

44- Jyonouchi H.; Sun S.; Mizokami M.; Gross MD. (1996)
Effects of various carotenoids on cloned, effector-stage T-helper cell activity. Nutr Cancer 26(3): 313-24.

45- Jyonouchi H.; Sun S.; Tomita Y.; Gross MD. (1995)
Astaxanthin, a carotenoid without vitamin A activity, augments antibody responses in cultures including T-helper cell clones and suboptimal doses of antigen. J Nutr 125(10): 2483-92.

46- Jyonouchi H.; Zhang L.; Gross M.; Tomita Y. (1994)
Immunomodulating actions of carotenoids: enhancement of in vivo and in vitro antibody production to T-dependent antigens. Nutr Cancer 21(1): 47-58.

47- Murillo E. (1992)
Cholesterolemic effects of canthaxanthin & astaxanthin in rats. Arc Latinoam Nutr. 42: 409-13.

48- Iwamoto T.; Hoosoda K.; Hirano R.; Kurata H.; Matsumoto A.; Miki W.; Kamiyama M.; Itakaru H.; Yamamoto S.; Kondo K. (2001)
Inhibition of low-density lipoprotein oxidation by astaxanthin. J Atheroscler Thromb 7: 216-22

49- Zhang LX.; Cooney RV.; Bertram JS. (1991)
Astaxanthin limits exercise-induced skeletal and cardiac muscle damage in mice. in C3H/10T1/2 cells: relationship to their cancer chemopreventative action. Carcinogenesis 12(11): 2109-14.

50- Aoi W.; Naito Y.; Sakuma K.; Kuchide M.; Tokuda H.; Maoka T.; Toyokuni S.; Oka S.; Yasuhara M.; Yoshikawa T. (2003)
Astaxanthin limits exercise-induced skeletal and cardiac muscle damage in mice. Antioxid Redox Signal 5(1): 139-44.

51- Kang JO.; Kim SJ.; Kim H. (2001)
Effect of astaxanthin on the hepatotoxicity, lipid peroxidation and antioxidative enzymes in the liver of CCl4-treated rats. Methods Find Exp Clin Pharmacol. 23(2): 79-84.

52- Murillo E. (1992)
Hypercholesterolemic effect of canthaxanthin and astaxanthin in rats. Arch Latinoam Nutr 42(4): 409-13.

53-Rengel D.; Diez-Navajas A.; Serna-Rico A.; Veiga P.; Muga A.; Milicua JC. (2000) Exogenously incorporated ketocarotenoids in large unilamellar vesicles. Protective activity against peroxidation. Biochim Biophys Acta 1463(1): 179-87.

54- Jyonouchi H.; Sun S.; Iijima K.; Gross MD. (2000)
Antitumour activity of astaxanthin and its mode of action. Nutr cancer 36(1): 59-65.

55- Kurihara H.; Koda H.; Asami S.; Kiso Y.; Tanaka T. (2002)
Contribution of the anti oxidative property of astaxanthin to its protective effect on the promotion of cancer metastasis in mice treated with resistant stress. Life Sci. 70(21): 2509-20.

56- Tanaka T.; Makita H.; Ohnishi M.; Mori H.; Satoh K.; Hara A. (1995)
Chemoprevention of rat oral carcinogenesis by naturally occurring xanthophylls, astaxanthin and canthaxanthin. Cancer Res. 55 (18): 4059-4064.

57- Tanaka T.; Morishita Y.; Suzui M.; Kojima T.; Okumura A.; Mori H. (1994) Chemoprevention of mouse urinary bladder carcinogenesis by the naturally occurring carotenoid astaxanthin. Carcinogenesis 15(1): 15-19.

58- Tanaka T.; Kawamori T.; Ohnishi M.; Makita H.; Mori H.; Satoh K.; Ha A. (1995) Suppression of azoxymethane-induced rat colon carcinogenesis by dietary administration of naturally occurring xanthophylls astaxanthin and canthaxanthin during the postinitiation phase. Carcinogenesis 16(12): 2957-63.

59- Rousseau EJ.; Davison AJ.; Dunn B. (1992)
Protection by beta-carotene and related compounds against oxygen-mediated cytotoxicity and genotoxicity: implications for carcinogenesis and anticarcinogenesis. Free Radic Biol Med 13(4): 407-33.

60- Kozuki Y.; Miura Y.; Yagasaki K. (2000)
Inhibitory effects of carotenoids on the invasion of rat ascites hepatoma cells in culture. Cancer Lett 151(1): 111-5

61- Gradelet S.; Le Bon AM.; Berges R.; Suschetet M.; Astorg P. (1998)
Dietary carotenoids inhibit aflatoxin B1-induced liver preneoplastic foci and DNA damage in the rat: role of the modulation of aflatoxin B1 metabolism. Carcinogenesis (3): 403-11.

62- Black HS. (1998)
Radical interception by carotenoids and effects on UV carcinogenesis. Nutr Cancer 31(3): 212-7.

63 - Nishino H.; Murakosh M.; Ii T.; Takemura M.; Kuchide M.; Kanazawa M.; Mou XY.; Wada S.; Masuda M.; Ohsaka Y.; Yogosawa S.; Satomi Y.; Jinno K. (2002)
Carotenoids in cancer chemoprevention. Cancer Metastasis Rev. 21(3-4): 257-64.

64- Li Z.; Wang Y.; Mo B. (2002)
The effects of carotenoids on the proliferation of human breast cancer cell and gene expression of bcl-2. Zhonghua Yu Fang Yi Xue Za Zhi. 36(4): 254-7.

65- Chew BP.; Park JS.; Wong MW.; Wong TS. (1999)
A comparison of the anticancer activities of dietary beta-carotene, canthaxanthin and astaxanthin in mice in vivo. Anticancer Res 19(3A): 1849-53.

66- Hansen KB.; Tauson AH.; Inborr J. (2001)
Effect of supplementation with the antioxidant astaxanthin on reproduction, pre-weaning growth performance of kits and daily milk intake in mink. J Reprod Fertil Suppl. 57: 331-4.

67- Lignell et al. (1998)
Method of increasing the production and improving the quality of semen. WO99/29313.

68- Lyons NM.; O'Brien NM. (2002)
Modulatory effects of an algal extract containing astaxanthin on UVA-irradiated cells in culture. J Dermatol Sci (1): 73-84.

69- Savoure N.; Briand G.; Amory-Touz MC.; Combre A.; Maudet M.; Nicol M. (1995) Vitamin A status and metabolism of cutaneous polyamines in the hairless mouse after UV irradiation: action of beta-carotene and astaxanthin. Int J Vitam Nutr Res 65(2): 79-86.

70- Skin et al. (2001)
Effects of astaxanthin from Haematococcus pluvialis on human skin. Fragrance Journal 12: 98-103.

71- Yamahita et al, (1995)
Suppression of post-UVB hyperpigmention by topical astaxanthin from krill. Fragrance Journal 14: 180-185.

72- R. Todd Lorenz.

Method for retarding and preventing sunburn by UV light. R. Patent no. US 6,433,025 B1 Cyanotech corporation.

73- Anderson, M. (2001)
Method of Inhibiting 5-a Reductase with Astaxanthin to Prevent and Treat Benign Prostate Hyperplasia (BPH) and Prostate Cancer in Human Males. US Patent #6277417.

74- Østerlie M.; Bjerkeng B.; Liaaen-Jensen S. (1999)
On bioavailability and deposition of bent Z-isomers of astaxanthin. In: Pigments in Food Technology. Proceedings of 1st International Congress PFT (Minguez Mosquera, M. I., Galan, M. J. & Mendez, D. H., eds) pp. 157-161. International Congress on Pigments in Food Technology, Sevilla, Spain

75- Østerlie M.; Bjerkeng B.; Liaaen-Jensen S. (1999)
Blood appearance and distribution of astaxanthin E/Z isomers among plasma lipoproteins in humans administered in a single meal with astaxanthin. Abstract 2A-13. Presented at the 12th International Symposium on Carotenoids in Cairns, Queensland, Australia, July 18-23, 1999.

76 - Østerlie M.; Bjerkeng B.; Liaaen-Jensen, S. (2000)
Plasma appearance and distribution of astaxanthin E/Z and R/S isomers in plasma lipoproteins of men after single dose administration of astaxanthin. J. Nutr. Biochem. 11: 482-490.

Additional References:

Britton, G., S. Liaaen-Jensen, and H. Pfander. (1995) Carotenoids today and challenges for the future. In: Britton, G., S. Liaaen-Jensen, and H. Pfander [eds], Carotenoids vol. 1A: Isolation and Analysis. Basel: Birkhäuser.

Lawlor, S. M. and O'Brien, N. M. (1995) Astaxanthin: antioxidant effects in chicken embryo fibroblasts. Nutr. Res., 15:1695-1704.

McCoy, M. (1999) Astaxanthin market a hard one to crack. Chem.& Eng. News, 77: 15-17.

Miki, W. (1991) Biological functions and activities of animal carotenoids. Pure Appl. Chem., 63(1):141-146.

Palozza, P. and Krinsky, N. I. (1992) Astaxanthin and canthaxanthin are potent antioxidants in a membrane model. Arch. Biochem. Biophys., 297:291-295.

Terao, J. (1989) Antioxidant activity of beta-carotene-related carotenoids in solution. Lipids, 24: 659-661.

Torrissen, O. J. and Christiansen, R. (1995) Requirements for carotenoids in fish diets. J. Appl. Ichthyol., 11:225-230.

Torrissen, O.J., R.W. Hardy, and K.D. Shearer. (1989) Pigmentation of salmonids--carotenoid deposition and metabolism. CRC Crit. Rev. Aquat. Sci., 1: 209-225.
FDA Disclaimer - Statements on this website have not been evaluated by the Food and Drug Administration. None of the products / services offered on this Web site are intended to diagnose, treat, cure or prevent any disease.